MEDPLUS HEALTH SERVICES Financial Statement Analysis
|
||
The Revenues of MEDPLUS HEALTH SERVICES have increased by 23.13% YoY .
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has decreased by -48.07 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
MEDPLUS HEALTH SERVICES Last 5 Annual Financial Results
[BOM: 543427|NSE : MEDPLUS]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹3,779 Cr | ₹3,069 Cr | ₹2,871 Cr | ₹2,273 Cr | ₹2,132 Cr |
Expenses | ₹3,490 Cr | ₹2,840 Cr | ₹2,737 Cr | ₹2,216 Cr | ₹2,073 Cr |
Operating Profit (Excl OI) | ₹289 Cr | ₹229 Cr | ₹134 Cr | ₹57 Cr | ₹59 Cr |
Other Income | ₹31 Cr | ₹22 Cr | ₹17 Cr | ₹9.83 Cr | ₹7.22 Cr |
Interest | ₹83 Cr | ₹67 Cr | ₹47 Cr | ₹16 Cr | ₹28 Cr |
Depreciation | ₹119 Cr | ₹88 Cr | ₹75 Cr | ₹14 Cr | ₹12 Cr |
Profit Before Tax | ₹118 Cr | ₹95 Cr | ₹29 Cr | ₹37 Cr | ₹26 Cr |
Profit After Tax | ₹95 Cr | ₹63 Cr | ₹1.79 Cr | ₹21 Cr | ₹42 Cr |
Consolidated Net Profit | ₹96 Cr | ₹64 Cr | ₹1.79 Cr | ₹21 Cr | ₹42 Cr |
Earnings Per Share (Rs) | ₹4.17 | ₹8.03 | ₹1,425.40 | ₹92.47 | ₹1,077.37 |
PAT Margin (%) | 1.08 | 2.47 | 2.01 | 0.06 | 0.92 |
ROE(%) | 3.50 | 9.07 | 12.96 | 0.59 | 6.81 |
ROCE(%) | 9.56 | 16.56 | 21.69 | 14.34 | 11.77 |
Total Debt/Equity(x) | 0.00 | 0.10 | 0.20 | 0.36 | 0.33 |
Key Financials |
||
Market Cap | : | ₹ 8,180.4 Cr |
Revenue (TTM) | : | ₹ 5,387.3 Cr |
Net Profit(TTM) | : | ₹ 58.6 Cr |
EPS (TTM) | : | ₹ 4.9 |
P/E (TTM) | : | 139.7 |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDPLUS HEALTH SERVICES | 0.6% | -2.2% | -5.9% |
SUN PHARMACEUTICAL INDUSTRIES | 3.6% | 3.3% | 64.3% |
DIVIS LABORATORIES | -2% | -6% | 21.5% |
CIPLA | 3.5% | -0.2% | 70.5% |
DR REDDYS LABORATORIES | -0.9% | -6.1% | 36.9% |
TORRENT PHARMACEUTICALS | 1.8% | -2.2% | 69.2% |
ABBOTT INDIA | -3.3% | -6.1% | 24.4% |
ZYDUS LIFESCIENCES | 2.9% | 6.1% | 112.8% |
ALKEM LABORATORIES | 4.5% | -1.2% | 55.6% |
MEDPLUS HEALTH SERVICES Revenues
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | 23.13 % |
5 Yr CAGR | 15.39 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹3,779 Cr | 23.13 | |
Mar2022 | ₹3,069 Cr | 6.92 | |
Mar2021 | ₹2,871 Cr | 26.31 | |
Mar2020 | ₹2,273 Cr | 6.61 | |
Mar2019 | ₹2,132 Cr | - |
MEDPLUS HEALTH SERVICES Operating Profit
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | 26.03 % |
5 Yr CAGR | 48.98 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹289 Cr | 26.03 | |
Mar2022 | ₹229 Cr | 71.47 | |
Mar2021 | ₹134 Cr | 135.34 | |
Mar2020 | ₹57 Cr | -3.13 | |
Mar2019 | ₹59 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 2.28 % |
5 Yr CAGR | 29.10 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 7.64% | 2.28 | |
Mar2022 | 7.47% | 60.30 | |
Mar2021 | 4.66% | 86.40 | |
Mar2020 | 2.5% | -9.09 | |
Mar2019 | 2.75% | - |
MEDPLUS HEALTH SERVICES Profit After Tax
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | 50.02 % |
5 Yr CAGR | 22.64 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹96 Cr | 50.02 | |
Mar2022 | ₹64 Cr | 3,459.53 | |
Mar2021 | ₹1.79 Cr | -91.42 | |
Mar2020 | ₹21 Cr | -50.65 | |
Mar2019 | ₹42 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -56.28 % |
5 Yr CAGR | 4.09 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 1.08 % | -56.28 | |
Mar2022 | 2.47 % | 22.89 | |
Mar2021 | 2.01 % | 3,250.00 | |
Mar2020 | 0.06 % | -93.48 | |
Mar2019 | 0.92 % | - |
MEDPLUS HEALTH SERVICES Earnings Per Share (EPS)
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | -48.07 % |
5 Yr CAGR | -75.06 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹4.17 | -48.07 | |
Mar2022 | ₹8.03 | -99.44 | |
Mar2021 | ₹1,425 | 1,441.47 | |
Mar2020 | ₹92 | -91.42 | |
Mar2019 | ₹1,077 | - |
MEDPLUS HEALTH SERVICES Return on Capital Employed (ROCE)
[BOM: 543427|NSE : MEDPLUS]
Y-o-Y | -42.27 % |
5 Yr CAGR | -5.07 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 9.56% | -42.27 | |
Mar2022 | 16.56% | -23.65 | |
Mar2021 | 21.69% | 51.26 | |
Mar2020 | 14.34% | 21.84 | |
Mar2019 | 11.77% | - |
MEDPLUS HEALTH SERVICES Share Price vs Sensex
Current Share Price | : | ₹684.6 |
Current MarketCap | : | ₹ 8,180.4 Cr |
Updated EOD on | : | Mar 27,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDPLUS HEALTH SERVICES | 0.6% |
-2.2% |
-5.9% |
SENSEX | 1.4% |
-0.2% |
25.7% |
MEDPLUS HEALTH SERVICES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE CONSUMER DISC. | 4% | -0.4% | 59.7% |
S&P BSE 250 SMALLCAP | 3.7% | -5.6% | 56.5% |
S&P BSE 400 MIDSMALLCAP | 3.6% | -3.6% | 55.7% |
S&P BSE SMALL CAP | 3.6% | -6.5% | 59.2% |
S&P BSE MIDSMALLCAP | 3.6% | -4.4% | 60.8% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY SMALLCAP250 | 4.1% | -5.8% | 61.9% |
NIFTY MID SMALL400 | 4% | -3.7% | 58.3% |
NIFTY500 MULTICAP 50:25:25 | 2.9% | -2.2% | 46.2% |
NIFTY 500 | 2.4% | -1.1% | 39.4% |
You may also like the below Video Courses
FAQ about MEDPLUS HEALTH SERVICES Financials
How the annual revenues of MEDPLUS HEALTH SERVICES have changed ?
The Revenues of MEDPLUS HEALTH SERVICES have increased by 23.13% YoY .
How the Earnings per Share (EPS) of MEDPLUS HEALTH SERVICES have changed?
The Earnings Per Share (EPS) of MEDPLUS HEALTH SERVICES has decreased by -48.07 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
DR REDDYS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD vs